Javascript must be enabled to continue!
The effect of zedoary essential components eluting stent on neointimal formation in a porcine restenosis model
View through CrossRef
Objective
To investigate the effect of zedoary essential components eluting stent (ZES) on porcine restenosis model.
Methods
ZES, sirolimus eluting stent (SES) and bare metal stent (BMS) were implanted in three different major epicardial vessel in 36 balloon-injured porcine model randomly. Coronary angiography, optical coherence tomography and histomorphologic analysis were performed after the procedure.
Results
Compared to the arteries implanted with BMS, there were significantly larger lumen diameter and area, and reduced diameter and area stenosis rate in the arteries with ZES or SES either at 30 days or 90 days, as follows: (30 days BMS: 1.43±0.31 mm and 1.92±0.63 mm2, 43.2±14.03 % and 47.12±15.18 %; ZES: 2.0±0.41 mm and 2.94±1.13 mm2, 21.4±22.3% and 27.7±23.95%; SES: 1.93±0.38 mm and 2.85±0.88 mm2, 24.5±12.93% and 26.8±16.81 %, p<0.01; (90 days BMS: 1.31±0.24 mm and 1.71±0.58 mm2, 48.2±13.11% and 51.17±17.14%; ZES: 1.97±0.36 mm and 2.71±1.01 mm2, 24.4±20.3% and 29.4±21.03%; SES: 1.91±0.27 mm and 2.67±0.61 mm2, 25.3±11.03% and 27.1±18.41%, p<0.01. By histomorphomeric analysis, moderate inflammatory responses cells were observed in some arteries with SES. Injury scores did not significantly differ among the three groups at 30 and 90 days. The endothelised score was 2.69±0.42 at 30 days, and 2.83±0.39 at 90 days, compared with ZES and BMS, p<0.05. No incomplete endothelium and inflammatory cells were observed in ZES arm.
Conclusion
ZES can reduce neointimal hyperplasia with good endothelia coverage in porcine balloon injured coronary model.
Title: The effect of zedoary essential components eluting stent on neointimal formation in a porcine restenosis model
Description:
Objective
To investigate the effect of zedoary essential components eluting stent (ZES) on porcine restenosis model.
Methods
ZES, sirolimus eluting stent (SES) and bare metal stent (BMS) were implanted in three different major epicardial vessel in 36 balloon-injured porcine model randomly.
Coronary angiography, optical coherence tomography and histomorphologic analysis were performed after the procedure.
Results
Compared to the arteries implanted with BMS, there were significantly larger lumen diameter and area, and reduced diameter and area stenosis rate in the arteries with ZES or SES either at 30 days or 90 days, as follows: (30 days BMS: 1.
43±0.
31 mm and 1.
92±0.
63 mm2, 43.
2±14.
03 % and 47.
12±15.
18 %; ZES: 2.
0±0.
41 mm and 2.
94±1.
13 mm2, 21.
4±22.
3% and 27.
7±23.
95%; SES: 1.
93±0.
38 mm and 2.
85±0.
88 mm2, 24.
5±12.
93% and 26.
8±16.
81 %, p<0.
01; (90 days BMS: 1.
31±0.
24 mm and 1.
71±0.
58 mm2, 48.
2±13.
11% and 51.
17±17.
14%; ZES: 1.
97±0.
36 mm and 2.
71±1.
01 mm2, 24.
4±20.
3% and 29.
4±21.
03%; SES: 1.
91±0.
27 mm and 2.
67±0.
61 mm2, 25.
3±11.
03% and 27.
1±18.
41%, p<0.
01.
By histomorphomeric analysis, moderate inflammatory responses cells were observed in some arteries with SES.
Injury scores did not significantly differ among the three groups at 30 and 90 days.
The endothelised score was 2.
69±0.
42 at 30 days, and 2.
83±0.
39 at 90 days, compared with ZES and BMS, p<0.
05.
No incomplete endothelium and inflammatory cells were observed in ZES arm.
Conclusion
ZES can reduce neointimal hyperplasia with good endothelia coverage in porcine balloon injured coronary model.
Related Results
Predictors of insistent restenosis in patients undergoing percutaneous intervention
Predictors of insistent restenosis in patients undergoing percutaneous intervention
Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. The first percutaneous coronary intervention was performed by Andreas Gruntzig on Septemb...
Effects of PIP targeting LOX-1 eluting stents on in-stent restenosis and re-endothelialisation in rat abdominal aorta stenting models
Effects of PIP targeting LOX-1 eluting stents on in-stent restenosis and re-endothelialisation in rat abdominal aorta stenting models
Background and Objectives
Pyrrole-Imidazole polyamide (PIP) is a novel gene silencer that can be readily designed and synthesised to target any gene. Contrary to ...
Crush Stenting With Paclitaxel-Eluting or Sirolimus-Eluting Stents for the Treatment of Coronary Bifurcation Lesions
Crush Stenting With Paclitaxel-Eluting or Sirolimus-Eluting Stents for the Treatment of Coronary Bifurcation Lesions
Two hundred forty-six patients with 252 bifurcation lesions were enrolled into a prospective, nonrandomized study to use paclitaxel-eluting or sirolimus-eluting stent for crush ste...
Incidence and Management of In-Stent Restenosis in Patients with Drug-Eluting Stents
Incidence and Management of In-Stent Restenosis in Patients with Drug-Eluting Stents
Introduction: The most prevalent complication of cardiac intervention is restenosis. After the BMS period, drug-eluting stents (DES) are the most suitable choice for stenosis treat...
Effectiveness and safety of the sirolimus‐eluting stents coated with bioabsorbable polymer coating in human coronary arteries
Effectiveness and safety of the sirolimus‐eluting stents coated with bioabsorbable polymer coating in human coronary arteries
AbstractBackground: Although the sirolimus‐eluting stent (CYPHER®, Cordis, USA) has shown a dramatic reduction of restenosis, there are still some concerns about its efficacy and s...
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
Objectives
To evaluate the efficacy and safety of domestic long biodegradable polymer coated sirolimus eluting stents (Excel stent, Shandong JW) for treatment of ...
In-stent restenosis in the drug-eluting stent era
In-stent restenosis in the drug-eluting stent era
For the last two decades, restenosis has been considered the most significant problem in interventional cardiology. Drug-eluting stents (DES) have reduced rates of restenosis and t...
e0473 Rapid re-endothelialization and anti-intimal hyperplasia coronary stent system with a novel biomacromolecular prohealing coating
e0473 Rapid re-endothelialization and anti-intimal hyperplasia coronary stent system with a novel biomacromolecular prohealing coating
Background
Rapid healing of endothelium on the coronary stent is a crucial method to prevent late stent thrombosis, a rare but life-threatening complication of dr...

